Group items tagged

The Pneumococcal Conjugate Vaccine is Known as Killed Vaccine. It uses protein or any other pieces extracted from the bacteria and injected into the immune system to recognize the bacteria.

The Pneumococcal Conjugate Vaccine is Known as Killed Vaccine. It uses protein or any other pieces extracted from the bacteria and injected into the immune system to recognize the bacteria.

The Pneumococcal Conjugate Vaccine is Known as Killed Vaccine. It uses protein or any other pieces extracted from the bacteria and injected into the immune system to recognize the bacteria.

GlaxoSmithKline on Tuesday (May 31) snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm. The London-listed company has agreed to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones for Affinivax. "GSK plc today announced that it has entered into a definitive agreement to acquire Affinivax, Inc," it said in a statement. "Affinivax is pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines," it added. The Cambridge, Massachusetts-based firm specialises in vaccines for diseases including meningitis, pneumonia and bloodstream infections. "The proposed acquisition further strengthens our vaccines research and development (R&D) pipeline, provides access to a new, potentially disruptive technology, and broadens GSK's existing scientific footprint in the Boston area," said GSK's chief scientific officer Hal Barron.

Hilleman laboratories vaccine research and science programs are focused on turning innovative science into practical solutions for developing countries.

Hilleman laboratories vaccine research and science programs are focused on turning innovative science into practical solutions for developing countries.

Hilleman laboratories vaccine research and science programs are focused on turning innovative science into practical solutions for developing countries.